MedPath

A Study of the Effectiveness and Safety of Ramipril in the Treatment of Hypertension in Children and Adolescents

Phase 3
Terminated
Conditions
Hypertension
Interventions
Drug: placebo
Registration Number
NCT00389519
Lead Sponsor
Pfizer
Brief Summary

The primary purpose of this study is to evaluate the blood pressure lowering effects of ramipril, an FDA-approved drug for the treatment of hypertension in adults, in children and adolescents aged 6 to 16 years with hypertension.

Detailed Description

Information is needed on the treatment of hypertension in children and adolescents with antihypertensive drugs like ramipril. The study will assess the safety and blood pressure effects of several doses of the antihypertensive drug ramipril in children and adolescents age 6-16 years. Approximately 450 children will be given placebo, or 1 of the 3 doses of ramipril. The treatment assigned will be done by chance, like flipping a coin. Approximately 120 study centers throughout the world will participate in the trial.

Each child will complete a 1- to 4-week Screening Period where they will stop taking their current blood pressure lowering drug(s), a 4-week Treatment Period where they will receive placebo or one of the ramipril doses, and a Follow-up visit 1 week after completion of the Treatment Period. Children diagnosed with hypertension according to the fourth report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescents (U.S. report), will be included in the study if their blood pressure meets certain values.

Each child will complete a minimum of 6 and up to 9 clinic visits over the course of the study during which procedures and assessments of blood pressure and safety will be performed. In addition, a child's parents/guardians will be instructed to measure their child's blood pressure at home between clinic visits.

A planned interim analysis was performed after approximately 240 subjects completed the trial. The study was stopped, as permitted by protocol, after the analysis.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
422
Inclusion Criteria
  1. Previous, documented diagnosis of hypertension, or newly diagnosed hypertension according to the fourth report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescents (United States). SiSBP greater than or equal to the 95th percentile for age, gender, and height.
  2. The subject can be safely withdrawn from antihypertensive medications during the screening period, and if given placebo during the treatment period in the judgment of the Investigator.
  3. The subject is male or female age 6 to 16 years (inclusive), and weighs greater than or equal to 20 kg.
  4. Female subjects greater than or equal to 12 years of age, or who have had greater than or equal to 1 menstruation must: (a) have a negative serum pregnancy test at screening (i.e., subject is not pregnant), (b) not be lactating, and (c) use an acceptable method of contraception.
  5. Parents/guardians are able to demonstrate their ability to (a) use a home blood pressure monitor supplied for the study to monitor their child's blood pressure, and (2) mix and administer a liquid dose of study drug if needed.
Exclusion Criteria
  1. Bilateral renal artery stenosis.
  2. Uncorrected coarctation of the aorta or corrected coarctation with a right arm/right leg blood pressure gradient greater than 10 mmHg.
  3. Severe hypertension.
  4. Renal transplantation or other previous solid organ transplantation less than 6 months prior to entering the study.
  5. Subjects with nephrotic syndrome not on stable maintenance therapy of prednisone or cyclosporine.
  6. A history of cardiomyopathy, clinically significant structural heart disease, or atrioventricular conduction disturbance, sick sinus syndrome, atrial flutter, atrial fibrillation, clinically significant bradycardia or an accessory bypass tract, or clinical symptoms of congestive heart failure.
  7. Clinically significant hematologic, hepatobiliary, or renal disease including a Schwartz formula GFR less than 40 mL/min/1.73 m2, and/or serum potassium (K+) greater than 5.5 mEq/L.
  8. History of pancreatitis (active or inactive).
  9. Known sensitivity to angiotensin converting enzyme inhibitors or a history of angioneurotic edema.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Placeboplaceboonce per day
ramipril low doseramipril0.3125, 0.625, or 1.25 mg once a day, based on subject weight
ramipril mid doseramipril1.25, 2.5, or 5 mg once a day, based on subject weight
ramipril high doseramipril5, 10, or 20 mg once a day, based on subject weight
Primary Outcome Measures
NameTimeMethod
Change From Baseline to 4 Weeks in Trough Sitting Systolic Blood PressureBaseline to 4 weeks

Value at end of treatment minus value at baseline, comparing the high-dose ramipril group with placebo

Secondary Outcome Measures
NameTimeMethod
Change From Baseline to 4 Weeks in Trough Sitting Diastolic Blood PressureBaseline to 4 weeks

Value at end of treatment minus value at baseline, comparing the high-dose ramipril group with placebo

Change From Baseline to 4 Weeks in Serum CreatinineBaseline up to 4 weeks

Value at end of treatment (up to 4 weeks) minus value at baseline

Change From Baseline to 4 Weeks in Serum PotassiumBaseline up to 4 weeks

Value at end of treatment (up to 4 weeks) minus value at baseline

Change From Baseline to 4 Weeks in Schwartz Formula Glomerular Filtration Rate (GFR)Baseline up to 4 weeks

Value at end of treatment (up to 4 weeks) minus value at baseline; GFR is a measure of kidney function.

Trial Locations

Locations (100)

Le Bonheur Children's Hospital

🇺🇸

Memphis, Tennessee, United States

Hospital de Niños "Dr. Ricardo Gutiérrez"

🇦🇷

Buenos Aires, Argentina

Hospital General Interzonal "Dr. José Penna"

🇦🇷

Buenos Aires, Argentina

Hospital Interzonal Especializado Materno Infantil

🇦🇷

Buenos Aires, Argentina

Premier Clinical Research Group

🇺🇸

Toms River, New Jersey, United States

University of North Carolina

🇺🇸

Chapel Hill, North Carolina, United States

Hospital Dr. Gustavo Fricke

🇨🇱

Vina del Mar, Chile

Heart Care Clinic

🇮🇳

Ahmedabad, India

Klinika Nefrologii Dzieciecej SPSK nr 1 ACK AMG

🇵🇱

Gdansk, Poland

Oddzial Pediatrii i Nefrologii ze Stacja Dializ, Wojewodzki Szpital Dzieciecy

🇵🇱

Torun, Poland

Uzhorod National University, Medical faculty, Department of Children's disease with course of Infection disease on the basis of City Children's Clinical Hospital.

🇺🇦

Uzhorod, Ukraine

Neufeld Medical Group

🇺🇸

Los Angeles, California, United States

Emory University

🇺🇸

Atlanta, Georgia, United States

Western Wake Pediatrics

🇺🇸

Cary, North Carolina, United States

Center for Clinical and Translational Research

🇺🇸

Columbus, Ohio, United States

Central Sooner Research

🇺🇸

Norman, Oklahoma, United States

Hawaii Pacific Health

🇺🇸

Honolulu, Hawaii, United States

Impact Clinical Trials

🇺🇸

Las Vegas, Nevada, United States

Children's Heart Center

🇺🇸

Las Vegas, Nevada, United States

Duke Pediatric Clinical Research Program

🇺🇸

Durham, North Carolina, United States

Cincinnati Children's Hospital Medical Center

🇺🇸

Cincinnati, Ohio, United States

Oregon Health and Science University

🇺🇸

Portland, Oregon, United States

University of Texas Medical Center

🇺🇸

Houston, Texas, United States

University of Utah

🇺🇸

Salt Lake City, Utah, United States

Hartrich Aquino & Hrab, PC

🇺🇸

Williamsville, New York, United States

Global Clinical Trial Centre

🇿🇦

Port Elizabeth, South Africa

Sandton Clinical Research Centre

🇿🇦

Sandton, South Africa

Klinika Nefrologii Pediatrycznej AM

🇵🇱

Wroclaw, Poland

Potchefstroom Medi-Clinic

🇿🇦

Potchefstroom, South Africa

Benmed Park Clinic

🇿🇦

Benoni, South Africa

Chris Hani Baragwanath

🇿🇦

Johannesburg, South Africa

Eastmed Medical centre

🇿🇦

Pretoria, South Africa

Marmara University Medical Faculty Pediatric Nephrology

🇹🇷

Istanbul, Turkey

Dokuzeylul University Medical Faculty Pediatric Nephrology

🇹🇷

Izmir, Turkey

Danylo Halytskiy Lviv NationalMedical University, Department of Faculty

🇺🇦

Lviv, Ukraine

Odessa State Medical University, Dept. of hospital pediatric and neonotology on the bases of Regional Children Hospital

🇺🇦

Odessa, Ukraine

Crim.St. Med. Uni. On b.o. Rep. Child.Clin.Hosp. Chair of Pediat. W.c. of Physioth. Of the Postgr.dept

🇺🇦

Simferopol, Ukraine

Vinnitsa National Medical Academy, Department of Hospital Pediatrics on the bases of Regional Pediatric Hospital

🇺🇦

Vinnitsa, Ukraine

Zuid Afrikaans Hospital

🇿🇦

Pretoria, South Africa

Pretoria Academic Hospital

🇿🇦

Pretoria, South Africa

Jubilee CTC Jubilee Hospital

🇿🇦

Pretoria, South Africa

UAMS College of Medicine/ Arkansas Children's Hospital

🇺🇸

Little Rock, Arkansas, United States

Woodland International Research Group, LLC

🇺🇸

Little Rock, Arkansas, United States

Impact Clinical Research

🇺🇸

Beverly Hills, California, United States

Almon Clinical Research, Inc.

🇺🇸

Orange, California, United States

Pediatrics in Brevard

🇺🇸

Cocoa Beach, Florida, United States

Watson Clinic Center for Research, Inc.

🇺🇸

Lakeland, Florida, United States

Medical College of Georgia

🇺🇸

Augusta, Georgia, United States

Tinley Park Pediatric Associates

🇺🇸

Tinley Park, Illinois, United States

Nephrology and Hypertension Consultants

🇺🇸

Park Ridge, Illinois, United States

Kosair Children's Hospital

🇺🇸

Louisville, Kentucky, United States

Louisiana State University

🇺🇸

Shreveport, Louisiana, United States

Craig Spiegel, MD

🇺🇸

Bridgeton, Missouri, United States

SUNY Upstate Syracuse, Department of Pediatrics

🇺🇸

Syracuse, New York, United States

North Carolina Children's and Adults Clinical Research Foundation

🇺🇸

Sylva, North Carolina, United States

Thomas Jefferson University Hospital

🇺🇸

Philadelphia, Pennsylvania, United States

The University of Oklahoma

🇺🇸

Tulsa, Oklahoma, United States

Northwest Pediatric Kidney Specialists, LLC

🇺🇸

Portland, Oregon, United States

Holston Medical Group

🇺🇸

Kingsport, Tennessee, United States

South East Texas Cardiology Associates

🇺🇸

Beaumont, Texas, United States

Huguenot Pediatrics

🇺🇸

Midlothian, Virginia, United States

University of Virginia

🇺🇸

Charlottesville, Virginia, United States

Children's Specialty Group

🇺🇸

Norfolk, Virginia, United States

Centro Infantil del Rínon

🇦🇷

Tucomán, Argentina

Hospital Italiano de Buenos Aires

🇦🇷

Buenos Aires, Argentina

Hospital de Niños Juan Carlos Navarro

🇦🇷

San Juan, Argentina

Clínica Las Condes

🇨🇱

Santiago, Chile

Hospital Luis Calvo Mackena

🇨🇱

Santiago, Chile

Fundación Bios

🇨🇴

Barranquilla, Colombia

Hospital de Niños Roberto del Rio

🇨🇱

Santiago, Chile

Instituto Nacional del Riñón

🇨🇴

Bogotá, Colombia

Gujarat Kidney Foundation, Jivraj Mehta Hospital

🇮🇳

Ahmedabad, India

Hospital de San Jose

🇨🇴

Bogotá, Colombia

Fundación Cardio Infantil - Instituto de Cardiología

🇨🇴

Bogotá, Colombia

KEM Hospital Research Centre

🇮🇳

Pune, India

Hospital Pablo Tobon Uribe

🇨🇴

Medellín, Colombia

Hospital Universitario San Vicente de Paul

🇨🇴

Medellin, Colombia

St. John's Hospital

🇮🇳

Bangalore, India

Apollo Hospital

🇮🇳

Delhi, India

Institute of Child Health & Hospital for Children

🇮🇳

Chennai, India

Maulana Azad Medical College and Lok Nayak Hospital

🇮🇳

Delhi, India

AIl India Institute medical sciences

🇮🇳

Delhi, India

Apollo Hospital Hyderabad

🇮🇳

Hyderabaad, India

Christian Medical College and Hospital

🇮🇳

Ludhiana, India

Nizam's Institute of Medical Sciences

🇮🇳

Hyderabaad, India

Jaslok Hospital and Research Centre

🇮🇳

Mumbai, India

Kerala Institute of Medical Science

🇮🇳

Trivandrum, India

Katedra i Klinika Kardiologii Dzieciecej SK nr 6, Gornoslaskie Centrum Zdrowia Dziecka i Matki, Slaska AM

🇵🇱

Katowice, Poland

II Katedra Pediatrii, Klinika Kardiologii Dzieciecej UM w Lodzi

🇵🇱

Lodz, Poland

Klinika Nefrologii i Dializoterapii, Instytut Centrum Zdrowia Matki Polki

🇵🇱

Lodz, Poland

Oddzial Nefrologi Dzieciecej ze Stacja Dializ SSP ZOZ nad Dziecklem i Mlodzieza

🇵🇱

Szczecin, Poland

Klinika Kardiologii i Nefrologii Dzieciecej AM

🇵🇱

Poznan, Poland

I Klinika Chorob Dzieci SPSK nr 1 PAM

🇵🇱

Szczecin, Poland

Kharkov State University,Dept. of hospital pediatric on the bases of Regional Children's Hospital

🇺🇦

Kharkov, Ukraine

Institute of Pediatrics and Obstetrics AMS of Ukraine, Department of ecology related health problems

🇺🇦

Kyiv, Ukraine

Istanbul University Istanbul Medical Faculty Pediatric Nephrology

🇹🇷

Istanbul, Turkey

Klinika Nefrologii i Transplantacji Nerek, Instytut Pomnik Centrum Zdrowia Dziecka

🇵🇱

Warszawa, Poland

Dnepropetrovsk Medical Academy, Department of Hospital Pediatrics on the bases of Regional Pediatric Hospital

🇺🇦

Dnepropetrovsk, Ukraine

Ondokummayis University Medical Faculty Pediatric Nephrology

🇹🇷

Samsun, Turkey

NMU n.b. Bogomolets, on b.o. Chil. Clin.Hosp.#2, Department of Pediatrics #2

🇺🇦

Kiev, Ukraine

© Copyright 2025. All Rights Reserved by MedPath